Feingold Daniel, Fox Jonah, Rehm Jürgen, Lev-Ran Shaul
Ariel University, Ariel, Israel.
Addiction Medicine and Dual Diagnosis Services, Department of Psychiatry, Sheba Medical Center, Tel Hashomer, Israel.
Addiction. 2015 Dec;110(12):1963-74. doi: 10.1111/add.13071. Epub 2015 Aug 26.
To assess the prevalence and correlates of remission from cannabis use disorders (CUDs), focusing on the proportion of individuals with CUDs that remit without abstaining from cannabis use.
Three-year longitudinal study.
Wave 1 (2001) and wave 2 (2004) of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC), a nationally representative sample of US adults aged 18 years and over.
Our sample included 444 individuals diagnosed with DSM-IV cannabis abuse and/or dependence during the 12 months prior to wave 1 of the NESARC.
Baseline socio-demographic and clinical correlates were analysed for possible outcomes of CUDs after 3 years: abstinent remission, non-abstinent remission and sustained disorder.
Approximately two-thirds (67%) of individuals with baseline CUD remitted at follow-up. Approximately 37% of those who remitted were non-abstinent. Remission was associated with Hispanic ethnicity [odds ratio (OR)=2.59; 95% confidence interval (CI)=1.27-4.87], baseline daily or almost daily use of cannabis (OR=1.91; 95% CI=1.15-3.16), baseline use of other drugs (OR=1.63; 95% CI=1.04-2.56) and two or more medical conditions at baseline (OR=8.40; 95% CI=2.67-26.41). Non-abstinent remission was associated with baseline daily or almost daily use of cannabis (OR=1.92; 95% CI=1.05-3.51).
A substantial level of remission from cannabis use disorders (CUDs), including non-abstinent remission, suggests that the nature of CUDs may be more unstable than reported previously.
评估大麻使用障碍(CUD)缓解的患病率及其相关因素,重点关注未戒除大麻使用但实现缓解的CUD个体比例。
三年纵向研究。
美国国家酒精及相关疾病流行病学调查(NESARC)的第1波(2001年)和第2波(2004年),这是一个具有全国代表性的18岁及以上美国成年人样本。
我们的样本包括在NESARC第1波之前12个月内被诊断为DSM-IV大麻滥用和/或依赖的444名个体。
分析了基线社会人口统计学和临床相关因素,以了解3年后CUD的可能结果:戒除缓解、非戒除缓解和持续性障碍。
基线时有CUD的个体中约三分之二(67%)在随访时实现缓解。缓解的个体中约37%未戒除。缓解与西班牙裔种族相关[比值比(OR)=2.59;95%置信区间(CI)=1.27 - 4.87]、基线时每天或几乎每天使用大麻(OR = 1.91;95% CI = 1.15 - 3.16)、基线时使用其他药物(OR = 1.63;95% CI = 1.04 - 2.56)以及基线时有两种或更多种疾病(OR = 8.40;95% CI = 2.67 - 26.41)有关。非戒除缓解与基线时每天或几乎每天使用大麻有关(OR = 1.92;95% CI = 1.05 - 3.51)。
大麻使用障碍(CUD)的缓解率较高,包括非戒除缓解,这表明CUD的性质可能比之前报道的更不稳定。